Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: (TSX: $ATD-A.TO; $ATD-B.TO) (TSX: $WEED.TO) (NYSE: $CGC), (TSXV: $RTI.V) (OTCQX: $RDDTF), (TSX: $TGOD.TO) (OTC: $TGODF)
Delta, Kelowna, BC – February 22, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/02221ATA-WEED-CGC-RTI-RDDTF-TGOD-TGODF.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com “potcast”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today we are looking at announcements from Alimentation Couche-Tard Inc. (TSX: ATD.A) (TSX: ATD.B),Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), Radient Technologies Inc. (TSXV:RTI) (OTCQX:RDDTF) and The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF).
Alimentation Couche-Tard Inc. announced that it has entered into a multi-year agreement with Canopy Growth Corporation.
Subsequent to this newly formed strategic partnership, and pending the results of a public-consultation process, Alimentation Couche-Tard announce that it has entered into a trademark license agreement with one of the winners of the Alcohol and Gaming Commission of Ontario's (the "AGCO") Expression of Interest Application Lottery, who will operate a "Tweed" branded retail store in London, Ontario, once the process is complete. The lottery winner will have full ownership and control over the London store.
Through this partnership, Alimentation Couche-Tard is aiming to lean on Canopy Growth's cannabis expertise and leverage its experience with other age-restricted products to focus on the safe, responsible and lawful sale of cannabis, consistent with the legislation enacted by the federal and provincial governments. As two Canadian-made and globally-positioned companies, the London location will serve as an important entry to market that could lead to future international opportunities.
"Alimentation Couche-Tard is excited about taking a leadership role in the development of cannabis retailing excellence in this major Canadian market. We believe the Ontario Cannabis Store and private retailers will co-exist under a tightly regulated framework with common goals to protect public health and safety," added Brian Hannasch.
Canopy Growth Corporation also announced the appointment of Dr. Danial Schecter as Director of Global Medical Services. Dr. Schecter is widely recognized as an expert in the clinical use of medical cannabis and will use his experience to expand the Company's network of partner healthcare clinics and support doctors and patients who understand the value of cannabis as medicine.
"I have had the honour of serving a range of patients who, after exhausting traditional pharmaceutical approaches, have reported the remarkable benefits of therapeutic cannabis," said Dr. Schecter. "As Canopy Growth's new Director of Global Medical Services, it will be my privilege to share the lessons learned from my vast clinical experience to benefit new cohorts of physicians and patients, both nationally and globally, who are able to access federally regulated medical cannabis."
Dr. Schecter's approach will rely on educational and outreach activities, including establishing new mentorship opportunities, developing training modules and organizing advisory boards that will assist healthcare providers in each jurisdiction that allows medical cannabis access. In addition, he will identify and support clinics partnered with Spectrum Cannabis and ensure they operate at the highest standards.
Radient Technologies Inc. announced that it has filed an additional 17 provisional patent applications with the United States Patent and Trademark Office . These applications cover inventions related to novel and improved methods and systems of consuming cannabis extracts and cannabis-infused products, in particular for medicinal cannabis consumers. These filings bring the total number of patent applications filed by the Company in 2018 and 2019 to 60, and mark the expansion of the Company’s intellectual property in the consumer and medical sectors of the cannabis and hemp industries.
In order to meet the growing consumer demand for safe cannabinoid-infused products and devices with an improved variety of delivery methods, the Patent Applications relate to novel devices capable of accurately monitoring cannabis consumption, providing relief from cannabis-induced side effects, and delivering cannabinoid extracts via alternate pathways (e.g. nasal, oral mucosal, transdermal, etc.).
Several of these inventions provide novel solutions which may reduce harm and discomfort associated with existing methods of consuming cannabis products, specifically for medicinal cannabis patients. For example, cannabis has traditionally been consumed by smoking, which has negative effects on the respiratory system. Alternatively, cannabis is often consumed orally, such as through the ingestion of cannabis ‘edibles’, which are associated with a delayed onset and bioavailability, as well as difficulties with controlling dosage. These inventions could eliminate or reduce the risks associated with cannabinoid dosage and delivery to create safer, standardized cannabinoid-infused products.
The Patent Applications also disclose methods of improving the experience of cannabis consumption for medicinal cannabis patients and consumers. These include methods for allowing cannabis consumers to share experiences over social media, testing methodologies for determining consumer preferences for product selection, and monitoring user biometrics to suggest consumption schedules.
The Patent Applications were first filed in the USPTO to create a priority date and allow for future filings in other selected jurisdictions, as appropriate, including Canada.
The Green Organic Dutchman Holdings Ltd. provided an update on its Jamaican partner Epican Medicinals Ltd.
In June 2018, TGOD purchased 49.18% interest in Epican, a fully integrated Jamaican cannabis company with cultivation, extraction, manufacturing and retail distribution licenses.
Significant progress has been made towards expanding cultivation, opening additional retail dispensaries, and establishing a leadership position in Jamaica's robust medical cannabis market.
Jamaica has long been recognized as a premier location for cannabis enthusiasts and Epican has deep roots in the country. Founders, the McKenzie brothers, have been at the forefront of the nation's burgeoning medical cannabis industry, including extensive advocacy for the responsible development of the industry. Epican was awarded the country's historic first cultivation license and continues to forge the path to serving the medical needs of the country's 3 million inhabitants and nearly 4.3 million tourists each year.
"We have made incredible progress in Jamaica over the past 8 months," commented Brian Athaide, Director and CEO of TGOD. "We plan to continue opening stores throughout the country, increasing productive capacity, and expanding our leadership in Jamaica. As Trelawny comes online in phases, we will accelerate production to meet growing demand within Jamaica and export product through TGOD's distribution channels in Mexico and beyond."
The 49.18% Jamaican investment is an integral component of TGOD's international strategy, together with distribution and operations in Europe, Latin America and North America provide the Company with a strong foundation to rapidly expand organic initiatives across the globe.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
